Bloodstream Infection Detection in ICU Patients:
From days to hours. What does molecular detection mean for the future of sepsis testing? Bloodstream infections don’t wait. Yet traditional diagnostics still do. In ICU settings, decisions are made within hours, often before blood culture results are available. The RADOS study takes a closer look at what happens when bacterial DNA is detected directly from blood, without the need for culture. How does this compare to standard methods? Where does it add value, and where does it create new challenges?
In this webinar, Anna Wijen from the Department of Medical Microbiology, Infectious Diseases & Infection Prevention at Maastricht University Medical Center will present the study and walk through the data from real ICU patients. She is joined by Dries Budding, CEO of inbiome, who will provide context on how molecular approaches are evolving and how they can be applied in practice.
What does this mean in practice?
- RADOS study design in ICU patients
- Molecular vs blood culture comparison
- Concordance and discordant cases
- Handling contaminants and unclear signals
- Clinical interpretation in practice
Join this webinar to explore the RADOS study in detail and understand how molecular detection is being evaluated in real ICU settings. We will also discuss what this approach could mean for future diagnostic workflows and decision-making in suspected bloodstream infections.
Agenda
- 5 mins — Welcome & Introductions
- 5 mins — Molecular Test by inbiome
- 30 mins — RADOS Study in ICU Patients
- 10 mins — Discussion & Q&A
- 5 mins — Closing
